• Robert B Nussenblatt and Curtis L Meinert.
• Laboratory of Immunology, National Eye Institute, National Institutes of Health, Building 10, Room 10N112, 10 Center Drive, Bethesda, MD 20892, USA. drbob@nei.nih.gov
• J Transl Med. 2010 Jan 1; 8: 65.

BackgroundAmericans see clinical research as important, with over 15 million American residents participating in NIH-sponsored studies in 2008 and growing yearly.MethodsDocuments reporting NIH supported Clinical Research projects were reviewed.ResultsWhen compared with other studies, the number of interventional Phase III and Phase IV trials have decreased from 20% to 4.4% from 1994-2008.ConclusionsThis finding most likely has occurred for several reasons. One reason is that the physician lacks an infrastructure for designing and carrying out trials. This lack is because of an absence of a coordinated effort to train clinical trialists. It is clear that the Nation needs a more purposeful approach to developing and maintaining the infrastructure for designing and conducting clinical trials. Building it de novo trial by trial is profoundly inefficient, to say nothing about time consuming and error prone.

5 keywords...

hide…